Med, Biotech & Pharma

Emerging Growth Medical, Biotechnology and Pharmaceutical Companies

Cancer Treatment

Propanc Health Group Corporation (OTCQB: PPCH) Rallies 9% After Announcing Presentation At Global Investment...

By: Matt Rego Propanc Health Group Corporation (OTCQB: PPCH) specializes in treatments for various cancers, such as pancreatic and colorectal cancers in Australia. The health...

Innovation Pharmaceuticals (IPIX) Announces Pre-IND Meeting Request Granted by FDA for the Study of...

Innovation Pharmaceuticals (IPIX) Announces Pre-IND Meeting Request Granted by FDA for the Study of Brilacidin for the Treatment of COVID-19
Glucose Health, Inc. (GLUC) Reports Record Sales Of GLUCODOWN® And New Advertising Campaign On Dish & Direct TV

Glucose Health, Inc. (GLUC) Reports Record Sales Of GLUCODOWN® And New Advertising Campaign On...

Miami, FL – May 13, 2020 (EmergingGrowth.com NewsWire) — EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled content for...

Innovation Pharmaceuticals’ (IPIX) Phase 2 Clinical Trial of Brilacidin for Treating COVID-19 Scheduled to...

Innovation Pharmaceuticals’ (IPIX) Phase 2 Clinical Trial of Brilacidin for Treating COVID-19 Scheduled to Begin Next Week

The top 3 Corona Virus stocks for 2021

Avalon GloboCare is in the process of establishing a state-of-the-art research facility, the Christian Doppler Laboratory, located on the BOKU campus in Vienna, Austria, under the scientific leadership of Professor Eva-Kathrin Ehmoser, the Head of BOKU’s Institute for Synthetic Bio architectures and Professor Uwe Sleytr, a member of the Austrian Academy of Sciences. In connection with the new facility, Avalon and BOKU have signed a Memorandum of Understanding (MOU) to jointly apply for a matching research grant from the prestigious Christian Doppler Laboratory Foundation. Avalon also has research being done in MIT (Massachusetts Institute of Technology), the UNRLS (University of Natural Resources and life sciences in Australia), Weill Cornell Medicine in New York City and the Lu Daopei Medical Group in China, which has the country’s top ranked hematology and bone marrow transplant program

Cocrystal Pharma, Inc. (OTCQB: COCP) Gains 15.13% After Receiving Private Placement Investment

Cocrystal Pharma, Inc. (OTCQB: COCP) is engaged as a biopharmaceutical company, which focuses on treatments for human viral diseases. Shares of the human virus...
OTCQB: PMCB

PharmaCyte Biotech (PMCB) to Submit Investigational New Drug Application to FDA for Clinical Trial...

Miami, FL – August 3, 2020 (EmergingGrowth.com NewsWire) — EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging...

Hands On or Off Cannabis Stocks

CLS Holdings USA, Inc. (OCTQB: CLSH) is a vertically integrated cannabis producer and retailer offering a wide variety of cannabis products through two subsidiaries: Oasis Cannabis and City Trees. The Company holds a U.S. Patent for a proprietary extraction and conversion methodology, which delivers products with a higher level of quality and consistency. The Company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting.

CLS Holdings USA, Inc. (OTCQB: CLSH) The Best Breed of Cannabis Stocks

The cannabis industry has been under intense pressure over the past year as regulatory indecisiveness worked its way into expansion plans.  At the height...
cbd-biopharmaceutical-company

Nemus Bioscience, Inc. (OTCQB: NMUS) Dives 42.45% After Announcing $500,000 Preferred Stock Financing

Nemus Bioscience, Inc. (OTCQB: NMUS) is engaged in the production, development, and commercialization of cannabinoid (CBD)-based treatments. Shares of the CBD biopharmaceutical company are...

Latest News